α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6. α-Synuclein and Rab1a affect the colocalization of Atg9 and LC3 vesicles. (A) Endogenous immunostaining of Atg9 and p230 in SKNSH cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (EGFP) was used as a control for cells expressing α-synuclein–GFP. Images shown are z-stack projections. The Atg9 panels show a clear dispersal of the perinuclear localization with α-synuclein overexpression or Rab1a knockdown. Golgi fragmentation can be seen in the p230 columns. α-Synuclein overexpression causes an increase in the disorganization of the Golgi structure, a phenotype which is amplified with Rab1a knockdown. (Magnifications of these images have been deposited in the JCB DataViewer.) (B) Quantification of Atg9 colocalization with p230 (Pearson’s coefficient; ***, P < 0.001; two-tailed Student’s t test; n = 10 from one representative experiment). (C) Immunostaining of endogenous Atg9 and LC3 in cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (GFP) was used as a control for cells expressing α-synuclein–GFP. Colocalization is highlighted in white on merged panel (image generated by ImageJ Colocalization plugin). Images are single confocal planes to more precisely determine colocalization. Arrows denote colocalization events. (Magnifications of these images have been deposited in the JCB DataViewer.) (D and E) Quantification of Atg9 colocalization with LC3 (Pearson’s [D] and Mander’s coefficient [E]). The Mander’s coefficient shown in the first bar graph in E more accurately predicts Atg9/LC3 colocalization when LC3 vesicle number is reduced by Rab1a knockdown or α-synuclein overexpression (*, P < 0.05; **, P < 0.01; ***, P < 0.001; two-tailed Student’s t test; n = 10). (B, D, and E) Error bars represent SEM. See related Fig. S3. Bars: (A) 20 µm; (C) 10 µm.](https://figures.cochat.ai/paper-figures/72d18dd1e8114fddb91346cb34772324/synuclein-impairs-macroautophagy-implications-for-parkinsons-disease-figure-6.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathologically meaningful levels of SNCA/α‐synuclein affect the intracellular localization of ATG9 via RAB1A (RAB1A, member RAS oncogene family), thereby perturbing autophagy dynamics in the brain of transgenic mice overexpressing SNCA/α‐synuclein (Winslow et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Winslow et al, 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Conversely, overexpression of wild-type synuclein impairs autophagic activity, implying a functional relationship between synuclein and autophagic degradation19.”
From Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice (2018) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · cited 2×
“Further lipidation of LC3-I creates the autophagosome-associated form, LC3-II, which is known to be a robust marker of autophagosomes (Kabeya et al., 2000).”
A guided tour into subcellular colocalization analysis in light microscopy
BOLTE, S., & CORDELIÈRES, F. P. (2006) · Journal of Microscopy · doi:10.1111/j.1365-2818.2006.01706.x · Cited by 5,324 · cited 1×
“Cells were imaged in z stacks, and images were analyzed by the JaCoP plugin (Bolte and Cordelières, 2006) in the ImageJ software.”
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082 · cited 2×
“In addition to the accumulation of aggregate-prone proteins, the cells will not be as effective in clearing dysfunctional mitochondria (Twig et al., 2008) and will have increased susceptibility to certain apoptotic insults (Ravikumar et al., 2006); these are all processes that have been implicated…”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · cited 2×
“Mice defective for macroautophagy die soon after birth, and neuronal knockouts of such genes cause neurodegeneration accompanied by inclusion formation (Kuma et al., 2004; Komatsu et al., 2005).”
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230 · cited 2×
“In this sense, the percentage of cells with mutant huntingtin aggregation can serve as a sensitive indicator of autophagic substrate clearance (Klionsky et al., 2008).”
Self-citationA Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118 · cited 1×
“62 (Jackson et al., 1998) with flies expressing wild-type -synuclein (UAS--syn; Feany and Bender, 2000) and with flies expressing constitutively active Rab1 (y1 P{UASp-YFP.”
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 8×
“Vol. 190 No. 6 1023–1037 www.jcb.org/cgi/doi/10.1083/jcb.201003122 JCB 1023 Correspondence to David C. Rubinsztein: dcr1000@hermes.cam.ac.uk Abbreviations used in this paper: ANOVA, analysis of variance; CMA, chaperonemediated autophagy; HD, Huntington’s disease; PD, Parkinson’s disease; PI(3)P, phosphatidylinositol-3…”
InfluentialAxe, E. L., Walker, S. A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., Griffiths, G., & Ktistakis, N. T. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803137 · Cited by 1,885 · cited 2×
“Thus, cells expressing GFP-labeled DFCP1 allow for the visualization of early events in autophagosome formation (Axe et al., 2008).”
Cited by
Items 401–500 of 826
Novel Targets for Parkinson’s Disease: Addressing Different Therapeutic Paradigms and Conundrums
Rane, P., Sarmah, D., Bhute, S., Kaur, H., Goswami, A., Kalia, K., Borah, A., Dave, K. R., Sharma, N., & Bhattacharya, P. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00180 · Cited by 37
Chauhan, A. K., & Mallick, B. N. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.04.019 · Cited by 36
Autophagy and Human Neurodegenerative Diseases—A Fly’s Perspective
Kim, M., Ho, A., & Lee, J. H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071596 · Cited by 36
“Still, α-syn in the Drosophila model was shown to directly interfere with autophagic flux, resulting in a pronounced accumulation of other autophagy substrates, such as mutant Huntingtin protein with a polyglutamine tract (see below) [66].”
BackgroundRole of Ceramides and Sphingolipids in Parkinson's Disease
Vos, M. H., Klein, C., & Hicks, A. A. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168000 · Cited by 48
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 37
α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
Bigi, A., Cascella, R., & Cecchi, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371345 · Cited by 40
“…mammalian cells and in transgenic mice, where it affects Rab1a-specific secretory pathways, hampering omegasome (autophagosome precursor) formation (Winslow et al., 2010), as well as to damage the autophagic flux in aging adult neurons through the inhibition of mitophagosome maturation and…”
BackgroundProtein recycling pathways in neurodegenerative diseases
Fecto, F., Esengul, Y. T., & Siddique, T. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt243 · Cited by 37
A Cleaning Crew: The Pursuit of Autophagy in Parkinson’s Disease
Parekh, P., Sharma, N., Gadepalli, A., Shahane, A., Sharma, M., & Khairnar, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00244 · Cited by 34
Tryphena, K. P., Singh, G., Jain, N., Famta, P., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111800 · Cited by 34
αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson’s Disease?
Protter, D. S. W., Lang, C., & Cooper, A. A. (2012) · Parkinson s Disease · doi:10.1155/2012/829207 · Cited by 47
“Interestingly, neither the αSynuclein mutants A30P nor A53T were found to impair macroautophagy [60].”
BackgroundA role for endoplasmic reticulum exit sites in foot-and-mouth disease virus infection
Midgley, R. J., Moffat, K., Berryman, S., Hawes, P. C., Simpson, J. L., Fullen, D. J., Stephens, D. J., Burman, A., & Jackson, T. (2013) · Journal of General Virology · doi:10.1099/vir.0.055442-0 · Cited by 37
“…(Rab1a and Rab1b) that are thought to be largely functionally redundant in the early secretory pathway (Tisdale et al., 1992), while Rab1a is also reported to play a role in early-endosome-to-Golgi trafficking (Mukhopadhyay et al., 2011; Sclafani et al., 2010) and autophagy (Winslow et al., 2010).”
BackgroundDirect and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity
Vijayakumaran, S., Wong, M. B., Antony, H., & Pountney, D. L. (2015) · Biomolecules · doi:10.3390/biom5031697 · Cited by 36
“Moreover, -synuclein is also implicated in the inhibition of macroautphagy via interaction with rab1a [42,43].”
BackgroundMelo, T. Q., van Zomeren, K. C., Ferrari, M., Boddeke, H. W. G. M., & Copray, J. C. V. M. (2016) · Experimental Brain Research · doi:10.1007/s00221-016-4836-9 · Cited by 35
“…whereas the knockdown of α-synuclein resulted in autophagy enhancement, suggesting that α-synuclein may have a regulatory role in autophagy (Winslow et al. 2010) The presence of damaged mitochondria by the direct action of (mutant) α-synuclein oligomers, on the contrary, appears to…”
BackgroundBansal, M., Moharir, S. C., & Swarup, G. (2018) · Communicative & Integrative Biology · doi:10.1080/19420889.2018.1467189 · Cited by 35
Li, Y.-Q., Yang, X.-J., Du, X., Lei, Y., He, Q., Hong, X., Tang, X.-R., Wen, X., Zhang, P., Sun, Y. H., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0532 · Cited by 35
Vicario, M., Cieri, D., Vallese, F., Catoni, C., Barazzuol, L., Berto, P., Grinzato, A., Barbieri, L., Brini, M., & Calí, T. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2092-1 · Cited by 38
Cheney, L., Guzik, H. M., Macaluso, F., Macián, F., Cuervo, A. M., & Berman, J. W. (2020) · Cells · doi:10.3390/cells9061426 · Cited by 35
Chen, X., & Burgoyne, R. D. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-71 · Cited by 37
Phadwal, K., Kurian, D., Salamat, M. K. F., MacRae, V. E., Diack, A. B., & Manson, J. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-28296-y · Cited by 36
Huang, Y. M., Chegini, F., Chua, G., Murphy, K., Gai, W.-P., & Halliday, G. M. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-2 · Cited by 33
Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease
Pan, P.-Y., Zhu, Y., Shen, Y., & Yue, Z. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.020 · Cited by 32
Pharmacological Tools to Modulate Autophagy in Neurodegenerative Diseases
Suresh, S. N., Chakravorty, A., Giridharan, M., Garimella, L., & Manjithaya, R. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.02.023 · Cited by 32
Padilla-Godínez, F. J., Ramos-Acevedo, R., Martínez-Becerril, H. A., Bernal-Conde, L. D., Garrido-Figueroa, J. F., Hiriart, M., Hernández-López, A., Argüero‐Sánchez, R., Callea, F., & Guerra‐Crespo, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212467 · Cited by 34
Mammalian autophagosomes form from finger-like phagophores
Puri, C., Gratian, M. J., & Rubinsztein, D. C. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.08.016 · Cited by 34
Self-citationChristensen, D. P., Ejlerskov, P., Rasmussen, I., & Vilhardt, F. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0519-5 · Cited by 35
Enfermedad de Parkinson: fisiopatología, diagnóstico y tratamiento
de Pereira, U. T., Marín, D. S., Villada, H. C., de Pereira, U. T., Ibarra, M., Grupo de Investigación “Applied Neuroscience”, N. R., Gámez-Cárdenas, M., & de Pereira, U. T. (2018) · Salud UIS · doi:10.18273/revsal.v50n1-2018008 · Cited by 71
Autophagy and lysosomal pathways in nervous system disorders
Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 34
Autophagy in ageing and ageing-related neurodegenerative diseases
Karabiyik, C., Frake, R. A., Park, S. J., Tanasa, M. P., & Rubinsztein, D. C. (2021) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.05 · Cited by 36
Self-citationDiab, R., Pilotto, F., & Saxena, S. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1086895 · Cited by 37
“Thus, ALR impairments might be causally associated with autophagy deficits and the accumulation of toxic α-synuclein species in the brain (Winslow et al., 2010; Magalhaes et al., 2016).”
BackgroundLiu, M., Liu, S., Lin, Z.-H., Chen, X., Jiao, Q., Du, X., & Jiang, H. F. (2025) · Biomolecules · doi:10.3390/biom15010149 · Cited by 33
“For instance, overexpression of α -synuclein enhances the interaction between Bcl-2 and Beclin1, reduces Rab 1a activity, and leads to the mislocalization of Atg9A, thereby compromising the formation of pre-phagophore [104].”
Das, S., Murumulla, L., Ghosh, P., & Challa, S. (2025) · BioMetals · doi:10.1007/s10534-025-00665-x · Cited by 32
“In PD, overexpression of α-synuclein, a major component of Lewy bodies, impairs macroautophagy by inhibiting Rab1a expression and disrupting Rab1a-mediated trafficking of Atg9, resulting in Atg9 mis-localization and impaired omegasome formation (Rai and Singh 2020; Winslow et al. 2010).”
Aberrant Autophagy and Parkinsonism: Does Correction Rescue from Disease Progression?
Mishra, A. K., Rasheed, M. S. U., Shukla, S., Tripathi, M. K., Dixit, A., & Singh, M. P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8744-3 · Cited by 33
“Atg9 encodes a trans-membrane protein, which moves to and from and is responsible for transport of the membrane to the site of autophagosome formation [2, 53, 54].”
Lamonaca, G., & Volta, M. (2020) · Cells · doi:10.3390/cells9051115 · Cited by 32
Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer’s Disease
Jordan, K. L., Koss, D. J., Outeiro, T. F., & Giorgini, F. (2022) · Biomedicines · doi:10.3390/biomedicines10051141 · Cited by 33
Rab6 is a Modulator of the Unfolded Protein Response: Implications for Alzheimer's Disease
Elfrink, H. L., Zwart, R., Cavanillas, M. L., Schindler, A. J., Baas, F., & Scheper, W. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110971 · Cited by 34
Crosstalk of Autophagy and the Secretory Pathway and Its Role in Diseases
Zahoor, M., & Farhan, H. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2017.12.004 · Cited by 31
“In mammals, ATG9 does not seem to become part of the autophagosome itself (Orsi et al, 2012).”
InfluentialPitcairn, C., Murata, N., Zalon, A. J., Stojkovska, I., & Mazzulli, J. R. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0610-22.2023 · Cited by 30
The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease
Bhat, S. A., Ahamad, S., Dar, N. J., Siddique, Y. H., & Nazir, A. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230216104621 · Cited by 31
“In contrast, a-synuclein overexpression mitigated autophagy and worsened HD progression in R6/1 and N171-82Q animals [129, 130].”
BackgroundEpigenetic regulation of autophagy in neuroinflammation and synaptic plasticity
Bai, I., Keyser, C., Zhang, Z., Rosolia, B. J., Hwang, J.-Y., Zukin, R. S., & Yan, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1322842 · Cited by 36
Chen, K., Yuan, R., Geng, S., Zhang, Y., Ran, T., Kowalski, E., Liu, J., & Li, L. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.10.002 · Cited by 28
Biomedical Implications of Autophagy in Macromolecule Storage Disorders
Palhegyi, A. M., Seranova, E., Dimova, S., Hoque, S., & Sarkar, S. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00179 · Cited by 33
“α-syn α-syn overexpression causes defective autophagy due to impaired autophagosome formation; mechanism via ATG9 mislocalization (Winslow et al., 2010) and cytoplasmic retention of TFEB (Decressac et al., 2013); whereas A53T and A30P α-syn mutants impair CMA (Cuervo et al., 2004; Martinez-Vicente…”
BackgroundInfluentialJiao, F., Meng, L., Du, K., & Li, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01195 · Cited by 33
Emerging roles of ATG9/ATG9A in autophagy: implications for cell and neurobiology
Choi, J., Jang, H., Xuan, Z., & Park, D. (2024) · Autophagy · doi:10.1080/15548627.2024.2384349 · Cited by 28
“The SNCA/α-synuclein overexpression-induced mislocalization of ATG9A is also detected in fibroblasts [124].”
Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health
Uytterhoeven, V., Verstreken, P., & Nachman, E. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202409104 · Cited by 29
Candidate genes for Parkinson disease: Lessons from pathogenesis
Rosa, P. D., Marini, E. S., Gelmetti, V., & Valente, E. M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.04.042 · Cited by 31
Convergent pathways in Parkinson’s disease
Cherubini, M., & Wade‐Martins, R. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2700-2 · Cited by 29
“For instance, αSyn overexpression can inhibit autophagosome biogenesis through interaction with the autophagy regulator Rab1a (Winslow et al. 2010).”
BackgroundFibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease
Kakoty, V., Sarathlal, K. C., Tang, R.-D., Yang, C. H., Dubey, S. K., & Taliyan, R. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110145 · Cited by 29
Boag, M. K., Roberts, A., Uversky, V. N., Ma, L., Richardson, D. R., & Pountney, D. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042378 · Cited by 32
Autophagy system as a potential therapeutic target for neurodegenerative diseases
Cui, M., Yoshimori, T., & Nakamura, S. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105308 · Cited by 29
Rabs, Membrane Dynamics, and Parkinson's Disease
Tang, B. L. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25713 · Cited by 32
“In addition, C9orf79 was shown to regulate autophagy through RAB1A’s regulation of recruitment of the Unc-51-like kinase 1 (ULK1) autophagy initiationcomplex to thephagophore (Webster et al., 2016).”
BackgroundKim, J. H., Yu, D.-H., Kim, H., Huh, Y. H., Cho, S., Lee, J.-K., Kim, H., & Kim, H. R. (2017) · Toxicology and Industrial Health · doi:10.1177/0748233717740066 · Cited by 31
Cho, B., Kim, T., Huh, Y.-J., Lee, J., & Lee, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205208 · Cited by 30
VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's Disease
Eleuteri, S., & Albanese, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01272 · Cited by 31
Fu, Y., Zhang, J., Qin, R., Ren, Y., Zhou, T., Han, B., & Liu, B. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100053 · Cited by 34
Wang, L., Li, X., Han, Y., Wang, T., Zhao, Y. F., Ali, A., El-Sayed, N. N. E., Shi, J., Wang, W., Fan, C., et al. (2016) · Science China Chemistry · doi:10.1007/s11426-016-0103-7 · Cited by 27
Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies
Lim, S., Kim, H., Kim, D., & Lee, S. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.010 · Cited by 28
The pROS of Autophagy in Neuronal Health
Sedlackova, L., Kelly, G., & Korolchuk, V. I. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.020 · Cited by 29
An Update on Autophagy in Prion Diseases
López-Pérez, Ó., Badiola, J., Bolea, R., Ferrer, I., Llorens, F., & Martín-Burriel, I. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00975 · Cited by 24
“…of several familial PD-associated molecules, such as the wild-type form and the mutant forms of α-synuclein, disrupts the autophagic machinery, suggesting that autophagy may play a relevant role in the pathogenesis of PD (Cuervo et al., 2004; Xilouri et al., 2009; Winslow et al., 2010).”
BackgroundLee, S. H., Shim, K. S., Kim, C. Y., & Park, T. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-85181-x · Cited by 27
Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
Magalhães, J. D., Fão, L., Vilaça, R., Cardoso, S. M., & Rego, A. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111625 · Cited by 30
“Cells harboring aSyn aggregates display an autophagosome build-up [205], which can be explained by the fact that aSyn inclusions promote the mislocalization of mATG9, a protein that facilitates membrane trafficking for phagophore formation [204].”
BackgroundParkinson’s Disease and Autophagy
Sánchez-Pérez, A. M., Clausell, B. C., Sanchez‐Andrés, J. V., & Herrero, M. T. (2012) · Parkinson s Disease · doi:10.1155/2012/429524 · Cited by 29
“However, overexpression of both mutant and wild type α-synuclein may also be accompanied by the induction of macroautophagy [31].”
BackgroundBatelli, S., Peverelli, E., Rodilossi, S., Forloni, G., & Albani, D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.030 · Cited by 27
Bachetti, T., & Ceccherini, I. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1150-5 · Cited by 30
Bennett, N., Chmielowski, R., Abdelhamid, D., Faig, J. J., Francis, N. L., Baum, J., Pang, Z., Uhrich, K., & Moghe, P. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.001 · Cited by 22
Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes
Chen, L.-L., Wu, J.-C., Wang, L.-H., Wang, J., Qin, Z.-H., Difiglia, M., & Lin, F. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.162 · Cited by 26
Revista Española de Geriatría y Gerontología
Santos, R. P., Torres, C. F., Martín‐Arranz, M. D., de Parga, J. M. S., & Martínez, M. A. (2016) · Cited by 26
Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds
Madsen, H. B., & Vilhardt, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010227 · Cited by 28
“The mechanisms range from inhibition of autophagosome formation [208,212,214,215], inhibition of cargo loading in selective autophagy [202] or chaperone-mediated autophagy [117,199], and deranged maturation typically by failure to fuse with lysosomes [191–193].”
BackgroundSelective autophagy: The new player in the fight against neurodegenerative diseases?
Wu, M.-Y., Song, J., Wang, S.-F., Cai, C.-Z., Li, M., & Lu, J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.11.009 · Cited by 29
Mohite, G. M., Navalkar, A., Kumar, R., Mehra, S., Das, S., Gadhe, L. G., Ghosh, D., Alias, B., Chandrawanshi, V., Ramakrishnan, A., et al. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00321 · Cited by 31
Effects of eEF1A2 knockdown on autophagy in an MPP+-induced cellular model of Parkinson’s disease
Prommahom, A., & Dharmasaroja, P. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.03.013 · Cited by 26
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Fouka, M., Mavroeidi, P., Tsaka, G., & Xilouri, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559791 · Cited by 29
“Beyond the UPS, increased α-synuclein has been reported to impair macroautophagy both in vitro and in vivo (Winslow et al., 2010), possibly through its interaction with Rab1a, which causes the mislocalization of Atg9, an autophagosome formation-related protein (Winslow et al., 2010).”
BackgroundThe Role of Autophagy in Manganese-Induced Neurotoxicity
Yan, D., & Xu, B. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.574750 · Cited by 29
Autophagy and Redox Homeostasis in Parkinson’s: A Crucial Balancing Act
Jiménez-Moreno, N., & Lane, J. D. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8865611 · Cited by 28
“, the A30P SNCA mutant impairs macroautophagy via inactivation of c-Jun and activation of the transcriptional repressor, ZKSCAN3 [515]) [519, 520].”
BackgroundMcGrath, K. M., Agarwal, S., Tonelli, M., Dergai, M., Gaeta, A. L., Shum, A. K., Lacoste, J., Zhang, Y., Wen, W., Chung, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016730118 · Cited by 26
Synaptic proteostasis in Parkinson's disease
Nachman, E., & Verstreken, P. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.09.001 · Cited by 31
The “Janus-Faced Role” of Autophagy in Neuronal Sickness: Focus on Neurodegeneration
Viscomi, M. T., & D’Amelio, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8296-3 · Cited by 27
The Coordinated Action of Calcineurin and Cathepsin D Protects Against α-Synuclein Toxicity
Aufschnaiter, A., Habernig, L., Kohler, V., Diessl, J., Carmona‐Gutiérrez, D., Eisenberg, T., Keller, W., & Büttner, S. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00207 · Cited by 30
“…Beal, 2016), deficiency in proteasomal degradation (Chung et al., 2001), imbalance of Ca2+ homeostasis (Büttner et al., 2013a; Rcom-H’cheo-Gauthier et al., 2016), lysosomal dysfunction (Tofaris, 2012; Bourdenx et al., 2014), and insufficient autophagy (Winslow et al., 2010; Lynch-Day et al., 2012).”
BackgroundInfluentialPollmanns, M. R., Beer, J., Rosignol, I., Rodríguez‐Muela, N., Falkenburger, B. H., & Dinter, E. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.861202 · Cited by 33
RAB39B's role in membrane traffic, autophagy, and associated neuropathology
Tang, B. L. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29962 · Cited by 27
“Furthermore, α‐Syn is known to block trafficking in the early exocytic pathway (A. A. Cooper et al., 2006), as well as impairing autophagy (Winslow et al., 2010). α‐Syn toxicity is rescued by RAB1A overexpression (A. A. Cooper et al., 2006; Coune, Bensadoun, Aebischer, & Schneider, 2011), and the…”
BackgroundPostmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?
Li, J., & Li, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.666675 · Cited by 28
Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity
Riera-Tur, I., Schäfer, T., Hornburg, D., Mishra, A., Padilha, M. D. S., Fernández-Mosquera, L., Feigenbutz, D., Auer, P., Mann, M., Baumeister, W. P., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202101185 · Cited by 35
“Conversely, aggregating proteins themselvesmightdirectly interferewiththe normalfunction of the autophagy-lysosomal machinery (Cuervo et al, 2004; Winslow et al, 2010; Wong & Holzbaur, 2014).”
Dual function of Rab1A in secretion and autophagy: hypervariable domain dependence
Gyurkovska, V., Murtazina, R., Zhao, S. F., Shikano, S., Okamoto, Y., & Segev, N. (2023) · Life Science Alliance · doi:10.26508/lsa.202201810 · Cited by 26
“In contrast, only Rab1A, and not Rab1B, has been associated with neurological disorders, for example, Parkinson ’ s disease (Winslow et al, 2010; Coune et al, 2011; Ejlerskov et al, 2013; Mazzulli et al, 2016; Hatstat et al, 2022), Alzheimer ’ s disease (Mohamed et al, 2017), amyotrophic lateral…”
InfluentialHa, J., Kim, J., Kim, S.-E., & Son, J. H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.064 · Cited by 26
Jowers, T. P., Featherstone, R. J., Reynolds, D. K., Brown, H. K., James, J. L., Prescott, A. R., Haga, I. R., & Beard, P. M. (2014) · Virology · doi:10.1016/j.virol.2014.11.007 · Cited by 24
“…al., 2009), the motility of early endocytotic vesicles, early endosome to Golgi traf fi cking (Mukhopadhyay et al., 2011), regulation of the actin cytoskeleton (Kicka et al., 2011), recycling of the integrin protein ITGB1 to the cell surface (Wang et al., 2010) and autophagy (Winslow et al., 2010).”
BackgroundLystad, A. H., & Simonsen, A. (2014) · Methods · doi:10.1016/j.ymeth.2014.12.019 · Cited by 27
Rab1A is required for assembly of classical swine fever virus particle
Lin, J., Wang, C., Liang, W., Zhang, J., Zhang, L., Lv, H., Dong, W., & Zhang, Y. (2017) · Virology · doi:10.1016/j.virol.2017.11.002 · Cited by 24
Kojima, W., Yamano, K., Kosako, H., Imai, K., Kikuchi, R., Tanaka, K., & Matsuda, N. (2021) · Autophagy · doi:10.1080/15548627.2021.1874133 · Cited by 27
Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson’s Disease
Martínez‐Menárguez, J. A., Martínez‐Alonso, E., Cara‐Esteban, M., & Tomás, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112087 · Cited by 26
“There are several differences in the roles of Rab1 isoforms [165].”
BackgroundInfluentialBridging the age spectrum of neurodegenerative storage diseases
Boland, B., & Platt, F. M. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.08.009 · Cited by 26
The In Vitro Effects of Enzymatic Digested Gliadin on the Functionality of the Autophagy Process
Manai, F., Azzalin, A., Gabriele, F., Martinelli, C., Morandi, M., Biggiogera, M., Bozzola, M., & Comincini, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020635 · Cited by 25
Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson’s disease
Tan, Y., Sgobio, C., Arzberger, T., Machleid, F., Tang, Q., Findeis, E., Tost, J., Chakroun, T., Gao, P., Höllerhage, M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02099-5 · Cited by 29
“Because α-syn-mediated neuronal cell death is associated with the inhibition of the ubiquitin/proteasome system (UPS) and with the alteration of autophagy [138], we also tested the effect of the UPS-inhibitor MG132 (1 μM, 6 h), and of the autophagy inhibitors bafilomycin A1 (100 nM, 6 h) and chloroquine (50 μM, 24 h)…”
MethodCheon, S. Y., Kim, J., Kim, S. Y., Kim, E. J., & Koo, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031103 · Cited by 24
A New Zebrafish Model to Measure Neuronal α-Synuclein Clearance In Vivo
López, A., Gorb, A., Palha, N., Fleming, A., & Rubinsztein, D. C. (2022) · Genes · doi:10.3390/genes13050868 · Cited by 28
“Multiple studies support the view that the accumulation of α-SYN compromises lysosomal degradation by impairing macro-autophagy and CMA in mammalian cells and transgenic mice [14,21,24,44,45].”
BackgroundSelf-citationJiao, F., Zhou, B., & Meng, L. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13985 · Cited by 25
Hull, A. J., Atilano, M. L., Gergi, L., & Kinghorn, K. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0381 · Cited by 30
“Overexpression of wild-type α Syn results in an indirect block to macroautophagy, contingent on inhibiting Rab1a-mediated trafficking of Atg9, a pre-autophagosomal regulator [67].”
A partial Drp1 knockout improves autophagy flux independent of mitochondrial function
Fan, R. Z., Sportelli, C., Lai, Y., Salehe, S. S., Pinnell, J. R., Brown, H. J., Richardson, J. R., Luo, S., & Tieu, K. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00708-w · Cited by 28
Hyun, C. H., Yoon, C. Y., Lee, H.-J., & Lee, S. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.4.249 · Cited by 27
VPS35 and retromer dysfunction in Parkinson's disease
Rowlands, J., & Moore, D. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0384 · Cited by 25
“Interestingly, mislocalization of ATG9A has also been observed in an α - synuclein overexpression model, often used to recapitulate familial forms of PD caused by SNCA ( α -synuclein) gene multiplication [64].”
BackgroundSzegő, É. M., Höfs, L., Antoniou, A., Dinter, E., Bernhardt, N. R., Schneider, A., Monte, D. A. D., & Falkenburger, B. H. (2025) · Nature Communications · doi:10.1038/s41467-025-59249-5 · Cited by 31
“Consistent with the known inhibition of autophagy by aSyn 43 , Mtor expression was increased in the SN of aSyn-AL mice as compared to GFP-AL control (Fig.”
Deciphering the Role Played by Autophagy in Leishmania Infection
Veras, P., de Menezes, J. D., & Dias, B. R. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02523 · Cited by 18
Metadata
- Authors
- Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., Brown, S., O’Kane, C. J., & Rubinsztein, D. C.
- Affiliations
- University of Cambridge (GB)
- Medical Research Council (GB)
- Mammalian Genetics Unit, Medical Research Council Harwell, Oxfordshire OX11 0RD, England, UK 4
- Corresponding author
- Rubinsztein, David C.
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2010-09-20
- Volume
- 190
- Issue
- 6
- Pages
- 1023-1037
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3101586
- OpenAlex
- W2142047537
- Cited by
- 825
- References
- 51
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 55 · 2023: 45 · 2022: 42 · 2021: 51 · 2020: 66 · 2019: 72 · 2018: 57 · 2017: 66 · 2016: 65 · 2015: 53 · 2014: 37 · 2013: 43 · 2012: 51
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- Wellcome Trust (FP7/2007–2013, 089703)
- European Commission (241791)
- Cambridge Trust
- Medical Research Council (MC_G1000734)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein, macroautophagy, Parkinson's disease, Rab1A, Atg9, Lewy bodies, transgenic mice
- MeSH terms
- Animals, Autophagy, Drosophila melanogaster, Golgi Apparatus, Humans, Membrane Proteins, Microtubule-Associated Proteins, Models, Biological, Parkinson Disease, Phagosomes, rab1 GTP-Binding Proteins, Protein Transport, Secretory Vesicles, Cell Line, Tumor, Mice, alpha-Synuclein, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.